DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr
DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr
Recruiting · NCT04106115 · Registry updated 2026-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Non-Muscle Invasive Bladder Neoplasms, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Phase 1 / Phase 2 | 2026-06-11 | NCT04106115 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Shionogi | 14 |
| University College, London | 222 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cambridge University NHS FT | Cambridge | United Kingdom | 1 |
| Guy's and St Thomas' NHS Foundation Trust | London | United Kingdom | 26 |
| Royal Free London NHS FT | London | United Kingdom | 1 |
| The Christie NHS Foundation Trust | Manchester | United Kingdom | 40 |
| The Royal Marsden NHS Foundation Trust | London | United Kingdom | 9 |
| University College London Hospital NHS Foundation Trust | London | United Kingdom | 2 |
| University Hospital Southampton NHS Foundation Trust | Southampton | United Kingdom | 24 |